{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T00:48:56Z","timestamp":1794703736930,"version":"4.9.1"},"reference-count":175,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1038\/s41584-022-00819-y","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T19:02:32Z","timestamp":1663268552000},"page":"559-574","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1578-4402","authenticated-orcid":false,"given":"Giorgio","family":"Trivioli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Marquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7572-7031","authenticated-orcid":false,"given":"Davide","family":"Martorana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelangelo","family":"Tesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2945-2946","authenticated-orcid":false,"given":"Andreas","family":"Kronbichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7035-8997","authenticated-orcid":false,"given":"Paul A.","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3814-9172","authenticated-orcid":false,"given":"Augusto","family":"Vaglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,15]]},"reference":[{"key":"819_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette, J. C. et al. 2012 revised international Chapel Hill consensus conference nomenclature of Vasculitides. Arthritis Rheum. 65, 1\u201311 (2013).","journal-title":"Arthritis Rheum."},{"key":"819_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/00005792-198403000-00001","volume":"63","author":"JG Lanham","year":"1984","unstructured":"Lanham, J. G., Elkon, K. B., Pusey, C. D. & Hughes, G. R. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine 63, 65\u201381 (1984).","journal-title":"Medicine"},{"key":"819_CR3","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/art.1780330807","volume":"33","author":"RY Leavitt","year":"1990","unstructured":"Leavitt, R. Y. et al. The American College of Rheumatology 1990 criteria for the classification of Wegener\u2019s granulomatosis. Arthritis Rheum. 33, 1101\u20131107 (1990).","journal-title":"Arthritis Rheum."},{"key":"819_CR4","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1002\/art.1780330806","volume":"33","author":"AT Masi","year":"1990","unstructured":"Masi, A. T. et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 33, 1094\u20131100 (1990).","journal-title":"Arthritis Rheum."},{"key":"819_CR5","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1136\/ard.59.6.478","volume":"59","author":"SF Sorensen","year":"2000","unstructured":"Sorensen, S. F., Slot, O., Tvede, N. & Petersen, J. A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature. Ann. Rheum. Dis. 59, 478\u2013482 (2000).","journal-title":"Ann. Rheum. Dis."},{"key":"819_CR6","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1136\/ard.2006.054593","volume":"66","author":"R Watts","year":"2007","unstructured":"Watts, R. et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann. Rheum. Dis. 66, 222\u2013227 (2007).","journal-title":"Ann. Rheum. Dis."},{"key":"819_CR7","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/art.41986","volume":"74","author":"JC Robson","year":"2022","unstructured":"Robson, J. C. et al. 2022 American College of Rheumatology\/European Alliance of Associations for rheumatology classification criteria for granulomatosis with polyangiitis. Arthritis Rheumatol. 74, 393\u2013399 (2022).","journal-title":"Arthritis Rheumatol."},{"key":"819_CR8","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/art.41983","volume":"74","author":"R Suppiah","year":"2022","unstructured":"Suppiah, R. et al. 2022 American College of Rheumatology\/European Alliance of Associations for rheumatology classification criteria for microscopic polyangiitis. Arthritis Rheumatol. 74, 400\u2013406 (2022).","journal-title":"Arthritis Rheumatol."},{"key":"819_CR9","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/art.41982","volume":"74","author":"PC Grayson","year":"2022","unstructured":"Grayson, P. C. et al. 2022 American College of Rheumatology\/European Alliance of Associations for rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis. Arthritis Rheumatol. 74, 386\u2013392 (2022).","journal-title":"Arthritis Rheumatol."},{"key":"819_CR10","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1046\/j.1523-1755.1998.00807.x","volume":"53","author":"EC Hagen","year":"1998","unstructured":"Hagen, E. C. et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC\/BCR Project for ANCA Assay Standardization. Kidney Int. 53, 743\u2013753 (1998).","journal-title":"Kidney Int."},{"key":"819_CR11","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJM198806233182504","volume":"318","author":"RJ Falk","year":"1988","unstructured":"Falk, R. J. & Jennette, J. C. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N. Engl. J. Med. 318, 1651\u20131657 (1988).","journal-title":"N. Engl. J. Med."},{"key":"819_CR12","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1172\/JCI114335","volume":"84","author":"R Goldschmeding","year":"1989","unstructured":"Goldschmeding, R. et al. Wegener\u2019s granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. J. Clin. Invest. 84, 1577\u20131587 (1989).","journal-title":"J. Clin. Invest."},{"key":"819_CR13","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1182\/blood.V75.11.2263.2263","volume":"75","author":"JC Jennette","year":"1990","unstructured":"Jennette, J. C., Hoidal, J. R. & Falk, R. J. Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3. Blood 75, 2263\u20132264 (1990).","journal-title":"Blood"},{"key":"819_CR14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1046\/j.1365-2796.1998.00357.x","volume":"244","author":"C Franssen","year":"1998","unstructured":"Franssen, C., Gans, R., Kallenberg, C., Hageluken, C. & Hoorntje, S. Disease spectrum of patients with antineutrophil cytoplasmic autoantibodies of defined specificity: distinct differences between patients with anti-proteinase 3 and anti-myeloperoxidase autoantibodies. J. Intern. Med. 244, 209\u2013216 (1998).","journal-title":"J. Intern. Med."},{"key":"819_CR15","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1002\/art.34562","volume":"64","author":"S Lionaki","year":"2012","unstructured":"Lionaki, S. et al. Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis. Arthritis Rheum. 64, 3452\u20133462 (2012).","journal-title":"Arthritis Rheum."},{"key":"819_CR16","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/annrheumdis-2012-201750","volume":"72","author":"A Mahr","year":"2013","unstructured":"Mahr, A. et al. Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis. Ann. Rheum. Dis. 72, 1003\u20131010 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"819_CR17","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1002\/art.39812","volume":"68","author":"EM Miloslavsky","year":"2016","unstructured":"Miloslavsky, E. M. et al. Myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)-positive and ANCA-negative patients with granulomatosis with polyangiitis (Wegener\u2019s): distinct patient subsets. Arthritis Rheumatol. 68, 2945\u20132952 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"819_CR18","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1002\/art.39786","volume":"68","author":"JH Schirmer","year":"2016","unstructured":"Schirmer, J. H. et al. Myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)-positive granulomatosis with polyangiitis (Wegener\u2019s) is a clinically distinct subset of ANCA-associated vasculitis: a retrospective analysis of 315 patients from a German vasculitis referral center. Arthritis Rheumatol. 68, 2953\u20132963 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"819_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/00005792-199901000-00003","volume":"78","author":"L Guillevin","year":"1999","unstructured":"Guillevin, L. et al. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine 78, 26\u201337 (1999).","journal-title":"Medicine"},{"key":"819_CR20","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1136\/annrheumdis-2012-201531","volume":"72","author":"F Moosig","year":"2013","unstructured":"Moosig, F. et al. A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients. Ann. Rheum. Dis. 72, 1011\u20131017 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"819_CR21","doi-asserted-by":"publisher","first-page":"632","DOI":"10.7326\/0003-4819-143-9-200511010-00006","volume":"143","author":"R Sable-Fourtassou","year":"2005","unstructured":"Sable-Fourtassou, R. et al. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann. Intern. Med. 143, 632\u2013638 (2005).","journal-title":"Ann. Intern. Med."},{"key":"819_CR22","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1002\/art.21250","volume":"52","author":"RA Sinico","year":"2005","unstructured":"Sinico, R. A. et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum. 52, 2926\u20132935 (2005).","journal-title":"Arthritis Rheum."},{"key":"819_CR23","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/art.37721","volume":"65","author":"C Comarmond","year":"2013","unstructured":"Comarmond, C. et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum. 65, 270\u2013281 (2013).","journal-title":"Arthritis Rheum."},{"key":"819_CR24","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202005-1628SO","author":"S Moiseev","year":"2020","unstructured":"Moiseev, S. et al. International consensus on ANCA testing in eosinophilic granulomatosis with polyangiitis. Am. J. Respir. Crit. Care Med. https:\/\/doi.org\/10.1164\/rccm.202005-1628SO (2020).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"819_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev-pathol-011811-132453","volume":"8","author":"JC Jennette","year":"2013","unstructured":"Jennette, J. C., Falk, R. J., Hu, P. & Xiao, H. Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis. Annu. Rev. Pathol. 8, 139\u2013160 (2013).","journal-title":"Annu. Rev. Pathol."},{"key":"819_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0014-5793(95)01073-N","volume":"374","author":"L Halbwachs-Mecarelli","year":"1995","unstructured":"Halbwachs-Mecarelli, L., Bessou, G., Lesavre, P., Lopez, S. & Witko-Sarsat, V. Bimodal distribution of proteinase 3 (PR3) surface expression reflects a constitutive heterogeneity in the polymorphonuclear neutrophil pool. FEBS Lett. 374, 29\u201333 (1995).","journal-title":"FEBS Lett."},{"key":"819_CR27","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","volume":"87","author":"RJ Falk","year":"1990","unstructured":"Falk, R. J., Terrell, R. S., Charles, L. A. & Jennette, J. C. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc. Natl Acad. Sci. USA. 87, 4115\u20134119 (1990).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"819_CR28","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.4049\/jimmunol.153.3.1271","volume":"153","author":"AJ Porges","year":"1994","unstructured":"Porges, A. J. et al. Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa. J. Immunol. 153, 1271\u20131280 (1994).","journal-title":"J. Immunol."},{"key":"819_CR29","first-page":"335","volume":"141","author":"CO Savage","year":"1992","unstructured":"Savage, C. O., Pottinger, B. E., Gaskin, G., Pusey, C. D. & Pearson, J. D. Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells. Am. J. Pathol. 141, 335\u2013342 (1992).","journal-title":"Am. J. Pathol."},{"key":"819_CR30","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1172\/JCI0215918","volume":"110","author":"H Xiao","year":"2002","unstructured":"Xiao, H. et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J. Clin. Invest. 110, 955\u2013963 (2002).","journal-title":"J. Clin. Invest."},{"key":"819_CR31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2353\/ajpath.2007.060573","volume":"170","author":"H Xiao","year":"2007","unstructured":"Xiao, H., Schreiber, A., Heeringa, P., Falk, R. J. & Jennette, J. C. Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies. Am. J. Pathol. 170, 52\u201364 (2007).","journal-title":"Am. J. Pathol."},{"key":"819_CR32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1681\/ASN.2008050497","volume":"20","author":"A Schreiber","year":"2009","unstructured":"Schreiber, A. et al. C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis. J. Am. Soc. Nephrol. 20, 289\u2013298 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"819_CR33","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa2023386","volume":"384","author":"DRW Jayne","year":"2021","unstructured":"Jayne, D. R. W., Merkel, P. A., Schall, T. J., Bekker, P. & Group, A. S. Avacopan for the treatment of ANCA-associated vasculitis. N. Engl. J. Med. 384, 599\u2013609 (2021).","journal-title":"N. Engl. J. Med."},{"key":"819_CR34","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1006\/clin.1994.1007","volume":"70","author":"OJ Mellbye","year":"1994","unstructured":"Mellbye, O. J., Mollnes, T. E. & Steen, L. S. IgG subclass distribution and complement activation ability of autoantibodies to neutrophil cytoplasmic antigens (ANCA). Clin. Immunol. Immunopathol. 70, 32\u201339 (1994).","journal-title":"Clin. Immunol. Immunopathol."},{"key":"819_CR35","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/1529-0131(199904)42:4<742::AID-ANR18>3.0.CO;2-I","volume":"42","author":"E Csernok","year":"1999","unstructured":"Csernok, E. et al. Cytokine profiles in Wegener\u2019s granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammation. Arthritis Rheum. 42, 742\u2013750 (1999).","journal-title":"Arthritis Rheum."},{"key":"819_CR36","first-page":"457","volume":"18","author":"U Schonermarck","year":"2000","unstructured":"Schonermarck, U., Csernok, E., Trabandt, A., Hansen, H. & Gross, W. L. Circulating cytokines and soluble CD23, CD26 and CD30 in ANCA-associated vasculitides. Clin. Exp. Rheumatol. 18, 457\u2013463 (2000).","journal-title":"Clin. Exp. Rheumatol."},{"key":"819_CR37","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/1529-0131(200102)44:2<469::AID-ANR66>3.0.CO;2-0","volume":"44","author":"M Kiene","year":"2001","unstructured":"Kiene, M. et al. Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg-Strauss syndrome. Arthritis Rheum. 44, 469\u2013473 (2001).","journal-title":"Arthritis Rheum."},{"key":"819_CR38","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1002\/art.23557","volume":"58","author":"WH Abdulahad","year":"2008","unstructured":"Abdulahad, W. H., Stegeman, C. A., Limburg, P. C. & Kallenberg, C. G. Skewed distribution of Th17 lymphocytes in patients with Wegener\u2019s granulomatosis in remission. Arthritis Rheum. 58, 2196\u20132205 (2008).","journal-title":"Arthritis Rheum."},{"key":"819_CR39","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1093\/ndt\/gfp783","volume":"25","author":"E Nogueira","year":"2010","unstructured":"Nogueira, E. et al. Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis. Nephrol. Dial. Transplant. 25, 2209\u20132217 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"issue":"1 Suppl 64","key":"819_CR40","first-page":"S57","volume":"29","author":"U Fagin","year":"2011","unstructured":"Fagin, U. et al. Distinct proteinase 3-induced cytokine patterns in Wegener s granulomatosis, Churg-Strauss syndrome, and healthy controls. Clin. Exp. Rheumatol. 29 (1 Suppl 64), S57\u2013S62 (2011).","journal-title":"Clin. Exp. Rheumatol."},{"key":"819_CR41","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1136\/bmj.281.6244.836","volume":"281","author":"AJ Pinching","year":"1980","unstructured":"Pinching, A. J. et al. Relapses in Wegener\u2019s granulomatosis: the role of infection. Br. Med. J. 281, 836\u2013838 (1980).","journal-title":"Br. Med. J."},{"key":"819_CR42","first-page":"1524","volume":"20","author":"JP Raynauld","year":"1993","unstructured":"Raynauld, J. P., Bloch, D. A. & Fries, J. F. Seasonal variation in the onset of Wegener\u2019s granulomatosis, polyarteritis nodosa and giant cell arteritis. J. Rheumatol. 20, 1524\u20131526 (1993).","journal-title":"J. Rheumatol."},{"key":"819_CR43","doi-asserted-by":"publisher","first-page":"12","DOI":"10.7326\/0003-4819-120-1-199401010-00003","volume":"120","author":"CA Stegeman","year":"1994","unstructured":"Stegeman, C. A. et al. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann. Intern. Med. 120, 12\u201317 (1994).","journal-title":"Ann. Intern. Med."},{"key":"819_CR44","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11926-015-0545-9","volume":"17","author":"RG Grau","year":"2015","unstructured":"Grau, R. G. Drug-induced vasculitis: new insights and a changing lineup of suspects. Curr. Rheumatol. Rep. 17, 71 (2015).","journal-title":"Curr. Rheumatol. Rep."},{"key":"819_CR45","doi-asserted-by":"publisher","first-page":"188","DOI":"10.2174\/1573397113666170517155443","volume":"13","author":"T Watanabe","year":"2017","unstructured":"Watanabe, T. Vasculitis following influenza vaccination: a review of the literature. Curr. Rheumatol. Rev. 13, 188\u2013196 (2017).","journal-title":"Curr. Rheumatol. Rev."},{"key":"819_CR46","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00296-021-05069-x","volume":"42","author":"A Prabhahar","year":"2022","unstructured":"Prabhahar, A. et al. ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based review. Rheumatol. Int. 42, 749\u2013758 (2022).","journal-title":"Rheumatol. Int."},{"key":"819_CR47","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0272-6386(00)70260-5","volume":"35","author":"M Yashiro","year":"2000","unstructured":"Yashiro, M. et al. Significantly high regional morbidity of MPO-ANCA-related angitis and\/or nephritis with respiratory tract involvement after the 1995 great earthquake in Kobe (Japan). Am. J. Kidney Dis. 35, 889\u2013895 (2000).","journal-title":"Am. J. Kidney Dis."},{"key":"819_CR48","doi-asserted-by":"publisher","first-page":"290","DOI":"10.2215\/CJN.03501006","volume":"2","author":"SL Hogan","year":"2007","unstructured":"Hogan, S. L. et al. Association of silica exposure with anti-neutrophil cytoplasmic autoantibody small-vessel vasculitis: a population-based, case-control study. Clin. J. Am. Soc. Nephrol. 2, 290\u2013299 (2007).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"819_CR49","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/art.10830","volume":"48","author":"SE Lane","year":"2003","unstructured":"Lane, S. E., Watts, R. A., Bentham, G., Innes, N. J. & Scott, D. G. Are environmental factors important in primary systemic vasculitis? A case-control study. Arthritis Rheum. 48, 814\u2013823 (2003).","journal-title":"Arthritis Rheum."},{"key":"819_CR50","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1002\/art.41722","volume":"73","author":"F Maritati","year":"2021","unstructured":"Maritati, F. et al. Occupational exposures and smoking in eosinophilic granulomatosis with polyangiitis: a case-control study. Arthritis Rheumatol. 73, 1694\u20131702 (2021).","journal-title":"Arthritis Rheumatol."},{"key":"819_CR51","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1093\/rheumatology\/ker205","volume":"50","author":"S Fujimoto","year":"2011","unstructured":"Fujimoto, S. et al. Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the UK. Rheumatology 50, 1916\u20131920 (2011).","journal-title":"Rheumatology"},{"key":"819_CR52","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.1093\/ndt\/gfn354","volume":"23","author":"RA Watts","year":"2008","unstructured":"Watts, R. A. et al. Renal vasculitis in Japan and the UK-are there differences in epidemiology and clinical phenotype? Nephrol. Dial. Transplant. 23, 3928\u20133931 (2008).","journal-title":"Nephrol. Dial. Transplant."},{"key":"819_CR53","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41584-021-00718-8","volume":"18","author":"RA Watts","year":"2022","unstructured":"Watts, R. A., Hatemi, G., Burns, J. C. & Mohammad, A. J. Global epidemiology of vasculitis. Nat. Rev. Rheumatol. 18, 22\u201334 (2022).","journal-title":"Nat. Rev. Rheumatol."},{"key":"819_CR54","first-page":"301","volume":"34","author":"M Weiner","year":"2019","unstructured":"Weiner, M. et al. Proteinase-3 and myeloperoxidase serotype in relation to demographic factors and geographic distribution in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. Nephrol. Dial. Transplant. 34, 301\u2013308 (2019).","journal-title":"Nephrol. Dial. Transplant."},{"key":"819_CR55","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1136\/ard.60.12.1156a","volume":"60","author":"RA Watts","year":"2001","unstructured":"Watts, R. A. et al. Epidemiology of vasculitis in Europe. Ann. Rheum. Dis. 60, 1156\u20131157 (2001).","journal-title":"Ann. Rheum. Dis."},{"key":"819_CR56","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1093\/rheumatology\/kem107","volume":"46","author":"AJ Mohammad","year":"2007","unstructured":"Mohammad, A. J., Jacobsson, L. T., Mahr, A. D., Sturfelt, G. & Segelmark, M. Prevalence of Wegener\u2019s granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden. Rheumatology 46, 1329\u20131337 (2007).","journal-title":"Rheumatology"},{"key":"819_CR57","doi-asserted-by":"publisher","first-page":"i14","DOI":"10.1093\/ndt\/gfv022","volume":"30","author":"RA Watts","year":"2015","unstructured":"Watts, R. A. et al. Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Nephrol. Dial. Transplant. 30, i14\u2013i22 (2015).","journal-title":"Nephrol. Dial. Transplant."},{"key":"819_CR58","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/art.23157","volume":"58","author":"A Knight","year":"2008","unstructured":"Knight, A., Sandin, S. & Askling, J. Risks and relative risks of Wegener\u2019s granulomatosis among close relatives of patients with the disease. Arthritis Rheum. 58, 302\u2013307 (2008).","journal-title":"Arthritis Rheum."},{"key":"819_CR59","first-page":"618","volume":"30","author":"P Manganelli","year":"2003","unstructured":"Manganelli, P., Giacosa, R., Fietta, P., Zanetti, A. & Neri, T. M. Familial vasculitides: Churg-Strauss syndrome and Wegener\u2019s granulomatosis in 2 first-degree relatives. J. Rheumatol. 30, 618\u2013621 (2003).","journal-title":"J. Rheumatol."},{"key":"819_CR60","doi-asserted-by":"publisher","first-page":"575219","DOI":"10.3389\/fimmu.2020.575219","volume":"11","author":"F Staels","year":"2020","unstructured":"Staels, F. et al. Adult-onset ANCA-associated vasculitis in SAVI: extension of the phenotypic spectrum, case report and review of the literature. Front. Immunol. 11, 575219 (2020).","journal-title":"Front. Immunol."},{"key":"819_CR61","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.kint.2022.02.031","volume":"101","author":"MV Lodi LM","year":"2022","unstructured":"Lodi LM, M. V. et al. Type I interferon-related kidney disorders. Kidney Int. 101, 1142\u20131159 (2022).","journal-title":"Kidney Int."},{"key":"819_CR62","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s00439-004-1092-z","volume":"114","author":"P Jagiello","year":"2004","unstructured":"Jagiello, P. et al. New genomic region for Wegener\u2019s granulomatosis as revealed by an extended association screen with 202 apoptosis-related genes. Hum. Genet. 114, 468\u2013477 (2004).","journal-title":"Hum. Genet."},{"key":"819_CR63","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1002\/art.22834","volume":"56","author":"A Vaglio","year":"2007","unstructured":"Vaglio, A. et al. HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome. Arthritis Rheum. 56, 3159\u20133166 (2007).","journal-title":"Arthritis Rheum."},{"key":"819_CR64","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1002\/art.27742","volume":"62","author":"AD Mahr","year":"2010","unstructured":"Mahr, A. D. et al. Alpha1-antitrypsin deficiency-related alleles Z and S and the risk of Wegener\u2019s granulomatosis. Arthritis Rheum. 62, 3760\u20133767 (2010).","journal-title":"Arthritis Rheum."},{"key":"819_CR65","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1046\/j.1523-1755.2000.00430.x","volume":"58","author":"M Gencik","year":"2000","unstructured":"Gencik, M., Meller, S., Borgmann, S. & Fricke, H. Proteinase 3 gene polymorphisms and Wegener\u2019s granulomatosis. Kidney Int. 58, 2473\u20132477 (2000).","journal-title":"Kidney Int."},{"key":"819_CR66","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.1002\/art.21487","volume":"52","author":"P Jagiello","year":"2005","unstructured":"Jagiello, P. et al. The PTPN22 620W allele is a risk factor for Wegener\u2019s granulomatosis. Arthritis Rheum. 52, 4039\u20134043 (2005).","journal-title":"Arthritis Rheum."},{"key":"819_CR67","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1084\/jem.20072413","volume":"205","author":"LC Willcocks","year":"2008","unstructured":"Willcocks, L. C. et al. Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake. J. Exp. Med. 205, 1573\u20131582 (2008).","journal-title":"J. Exp. Med."},{"key":"819_CR68","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/j.jaci.2015.09.053","volume":"137","author":"D Martorana","year":"2016","unstructured":"Martorana, D. et al. Fc\u03b3-receptor 3B (FCGR3B) copy number variations in patients with eosinophilic granulomatosis with polyangiitis. J. Allergy Clin. Immunol. 137, 1597\u20131599.e8 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"819_CR69","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1136\/annrheumdis-2012-202803","volume":"73","author":"CA Husmann","year":"2014","unstructured":"Husmann, C. A. et al. Genetics of toll like receptor 9 in ANCA associated vasculitides. Ann. Rheum. Dis. 73, 890\u2013896 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"819_CR70","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1056\/NEJMoa1108735","volume":"367","author":"PA Lyons","year":"2012","unstructured":"Lyons, P. A. et al. Genetically distinct subsets within ANCA-associated vasculitis. N. Engl. J. Med. 367, 214\u2013223 (2012).","journal-title":"N. Engl. J. Med."},{"key":"819_CR71","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1002\/art.38036","volume":"65","author":"G Xie","year":"2013","unstructured":"Xie, G. et al. Association of granulomatosis with polyangiitis (Wegener\u2019s) with HLA-DPB1*04 and SEMA6A gene variants: evidence from genome-wide analysis. Arthritis Rheum. 65, 2457\u20132468 (2013).","journal-title":"Arthritis Rheum."},{"key":"819_CR72","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1002\/art.40034","volume":"69","author":"PA Merkel","year":"2017","unstructured":"Merkel, P. A. et al. Identification of functional and expression polymorphisms associated with risk for antineutrophil cytoplasmic autoantibody-associated vasculitis. Arthritis Rheumatol. 69, 1054\u20131066 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"819_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12515-9","volume":"10","author":"PA Lyons","year":"2019","unstructured":"Lyons, P. A. et al. Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status. Nat. Commun. 10, 5120 (2019).","journal-title":"Nat. Commun."},{"key":"819_CR74","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1172\/JCI40034","volume":"120","author":"DJ Ciavatta","year":"2010","unstructured":"Ciavatta, D. J. et al. Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis. J. Clin. Invest. 120, 3209\u20133219 (2010).","journal-title":"J. Clin. Invest."},{"key":"819_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-016-0251-0","volume":"8","author":"J Yang","year":"2016","unstructured":"Yang, J. et al. Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Clin. Epigenetics 8, 85 (2016).","journal-title":"Clin. Epigenetics"},{"key":"819_CR76","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1681\/ASN.2016050548","volume":"28","author":"BE Jones","year":"2017","unstructured":"Jones, B. E. et al. Gene-specific DNA methylation changes predict remission in patients with ANCA-associated vasculitis. J. Am. Soc. Nephrol. 28, 1175\u20131187 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"819_CR77","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/rheumatology\/ker446","volume":"51","author":"D Martorana","year":"2012","unstructured":"Martorana, D. et al. PTPN22 R620W polymorphism in the ANCA-associated vasculitides. Rheumatology 51, 805\u2013812 (2012).","journal-title":"Rheumatology"},{"key":"819_CR78","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1093\/rheumatology\/kep420","volume":"49","author":"S Wieczorek","year":"2010","unstructured":"Wieczorek, S. et al. Contrasting association of a non-synonymous leptin receptor gene polymorphism with Wegener\u2019s granulomatosis and Churg-Strauss syndrome. Rheumatology 49, 907\u2013914 (2010).","journal-title":"Rheumatology"},{"key":"819_CR79","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/ng2046","volume":"39","author":"M Fanciulli","year":"2007","unstructured":"Fanciulli, M. et al. FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat. Genet. 39, 721\u2013723 (2007).","journal-title":"Nat. Genet."},{"key":"819_CR80","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1002\/art.23496","volume":"58","author":"S Wieczorek","year":"2008","unstructured":"Wieczorek, S. et al. Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome, but not with Wegener\u2019s granulomatosis. Arthritis Rheum. 58, 1839\u20131848 (2008).","journal-title":"Arthritis Rheum."},{"key":"819_CR81","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1093\/rheumatology\/kep280","volume":"48","author":"L Kamesh","year":"2009","unstructured":"Kamesh, L. et al. CT60 and +49 polymorphisms of CTLA 4 are associated with ANCA-positive small vessel vasculitis. Rheumatology 48, 1502\u20131505 (2009).","journal-title":"Rheumatology"},{"key":"819_CR82","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab912","author":"J Dahlqvist","year":"2021","unstructured":"Dahlqvist, J. et al. Identification and functional characterization of a novel susceptibility locus for small vessel vasculitis with MPO-ANCA. Rheumatology https:\/\/doi.org\/10.1093\/rheumatology\/keab912 (2021).","journal-title":"Rheumatology"},{"key":"819_CR83","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1136\/ard.2007.077693","volume":"67","author":"M Heckmann","year":"2008","unstructured":"Heckmann, M. et al. The Wegener\u2019s granulomatosis quantitative trait locus on chromosome 6p21.3 as characterised by tagSNP genotyping. Ann. Rheum. Dis. 67, 972\u2013979 (2008).","journal-title":"Ann. Rheum. Dis."},{"key":"819_CR84","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/sj.gene.6364262","volume":"7","author":"N Tsuchiya","year":"2006","unstructured":"Tsuchiya, N., Kobayashi, S., Hashimoto, H., Ozaki, S. & Tokunaga, K. Association of HLA-DRB1*0901-DQB1*0303 haplotype with microscopic polyangiitis in Japanese. Genes Immun. 7, 81\u201384 (2006).","journal-title":"Genes Immun."},{"key":"819_CR85","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/art.23209","volume":"58","author":"S Wieczorek","year":"2008","unstructured":"Wieczorek, S., Hellmich, B., Gross, W. L. & Epplen, J. T. Associations of Churg-Strauss syndrome with the HLA-DRB1 locus, and relationship to the genetics of antineutrophil cytoplasmic antibody-associated vasculitides: comment on the article by Vaglio et al. Arthritis Rheum. 58, 329\u2013330 (2008).","journal-title":"Arthritis Rheum."},{"key":"819_CR86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154393","volume":"11","author":"A Kawasaki","year":"2016","unstructured":"Kawasaki, A. et al. Protective role of HLA-DRB1*13:02 against microscopic polyangiitis and MPO-ANCA-positive vasculitides in a Japanese population: a case-control study. PLoS ONE 11, e0154393 (2016).","journal-title":"PLoS ONE"},{"key":"819_CR87","first-page":"1534","volume":"30","author":"N Tsuchiya","year":"2003","unstructured":"Tsuchiya, N. et al. Genetic background of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: association of HLA-DRB1*0901 with microscopic polyangiitis. J. Rheumatol. 30, 1534\u20131540 (2003).","journal-title":"J. Rheumatol."},{"key":"819_CR88","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00109-009-0580-y","volume":"88","author":"S Wieczorek","year":"2010","unstructured":"Wieczorek, S. et al. A functionally relevant IRF5 haplotype is associated with reduced risk to Wegener\u2019s granulomatosis. J. Mol. Med. 88, 413\u2013421 (2010).","journal-title":"J. Mol. Med."},{"key":"819_CR89","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s10038-017-0362-2","volume":"63","author":"A Kawasaki","year":"2018","unstructured":"Kawasaki, A. et al. Association of ETS1 polymorphism with granulomatosis with polyangiitis and proteinase 3-anti-neutrophil cytoplasmic antibody positive vasculitis in a Japanese population. J. Hum. Genet. 63, 55\u201362 (2018).","journal-title":"J. Hum. Genet."},{"key":"819_CR90","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1002\/art.21653","volume":"54","author":"R Miyashita","year":"2006","unstructured":"Miyashita, R. et al. Association of killer cell immunoglobulin-like receptor genotypes with microscopic polyangiitis. Arthritis Rheum. 54, 992\u2013997 (2006).","journal-title":"Arthritis Rheum."},{"key":"819_CR91","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/gene.2009.44","volume":"10","author":"S Wieczorek","year":"2009","unstructured":"Wieczorek, S. et al. Novel association of the CD226 (DNAM-1) Gly307Ser polymorphism in Wegener\u2019s granulomatosis and confirmation for multiple sclerosis in German patients. Genes Immun. 10, 591\u2013595 (2009).","journal-title":"Genes Immun."},{"key":"819_CR92","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/gene.2008.5","volume":"9","author":"K Mamegano","year":"2008","unstructured":"Mamegano, K. et al. Association of LILRA2 (ILT1, LIR7) splice site polymorphism with systemic lupus erythematosus and microscopic polyangiitis. Genes Immun. 9, 214\u2013223 (2008).","journal-title":"Genes Immun."},{"key":"819_CR93","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.kint.2019.06.015","volume":"96","author":"HY Wang","year":"2019","unstructured":"Wang, H. Y. et al. Risk HLA class II alleles and amino acid residues in myeloperoxidase-ANCA-associated vasculitis. Kidney Int. 96, 1010\u20131019 (2019).","journal-title":"Kidney Int."},{"key":"819_CR94","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/j.1365-2796.1994.tb00842.x","volume":"236","author":"AN Elzouki","year":"1994","unstructured":"Elzouki, A. N., Segelmark, M., Wieslander, J. & Eriksson, S. Strong link between the alpha 1-antitrypsin PiZ allele and Wegener\u2019s granulomatosis. J. Intern. Med. 236, 543\u2013548 (1994).","journal-title":"J. Intern. Med."},{"key":"819_CR95","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/nrrheum.2014.109","volume":"10","author":"SM Stanford","year":"2014","unstructured":"Stanford, S. M. & Bottini, N. PTPN22: the archetypal non-HLA autoimmunity gene. Nat. Rev. Rheumatol. 10, 602\u2013611 (2014).","journal-title":"Nat. Rev. Rheumatol."},{"key":"819_CR96","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/ng1323","volume":"36","author":"N Bottini","year":"2004","unstructured":"Bottini, N. et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 36, 337\u2013338 (2004).","journal-title":"Nat. Genet."},{"key":"819_CR97","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1086\/422827","volume":"75","author":"AB Begovich","year":"2004","unstructured":"Begovich, A. B. et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 75, 330\u2013337 (2004).","journal-title":"Am. J. Hum. Genet."},{"key":"819_CR98","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1086\/423790","volume":"75","author":"C Kyogoku","year":"2004","unstructured":"Kyogoku, C. et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am. J. Hum. Genet. 75, 504\u2013507 (2004).","journal-title":"Am. J. Hum. Genet."},{"key":"819_CR99","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1136\/annrheumdis-2013-203641","volume":"72","author":"A Serrano","year":"2013","unstructured":"Serrano, A. et al. Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis. Ann. Rheum. Dis. 72, 1882\u20131886 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"819_CR100","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.semarthrit.2021.03.004","volume":"51","author":"K Tizaoui","year":"2021","unstructured":"Tizaoui, K. et al. The role of PTPN22 in the pathogenesis of autoimmune diseases: a comprehensive review. Semin. Arthritis Rheum. 51, 513\u2013522 (2021).","journal-title":"Semin. Arthritis Rheum."},{"key":"819_CR101","first-page":"950","volume":"29","author":"R Giscombe","year":"2002","unstructured":"Giscombe, R., Wang, X., Huang, D. & Lefvert, A. K. Coding sequence 1 and promoter single nucleotide polymorphisms in the CTLA-4 gene in Wegener\u2019s granulomatosis. J. Rheumatol. 29, 950\u2013953 (2002).","journal-title":"J. Rheumatol."},{"key":"819_CR102","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1002\/art.20385","volume":"50","author":"Y Zhou","year":"2004","unstructured":"Zhou, Y. et al. An analysis of CTLA-4 and proinflammatory cytokine genes in Wegener\u2019s granulomatosis. Arthritis Rheum. 50, 2645\u20132650 (2004).","journal-title":"Arthritis Rheum."},{"key":"819_CR103","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.clim.2008.03.506","volume":"128","author":"MC Slot","year":"2008","unstructured":"Slot, M. C. et al. Immunoregulatory gene polymorphisms are associated with ANCA-related vasculitis. Clin. Immunol. 128, 39\u201345 (2008).","journal-title":"Clin. Immunol."},{"key":"819_CR104","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s11033-011-0741-2","volume":"39","author":"YH Lee","year":"2012","unstructured":"Lee, Y. H., Choi, S. J., Ji, J. D. & Song, G. G. CTLA-4 and TNF-\u03b1 promoter-308 A\/G polymorphisms and ANCA-associated vasculitis susceptibility: a meta-analysis. Mol. Biol. Rep. 39, 319\u2013326 (2012).","journal-title":"Mol. Biol. Rep."},{"key":"819_CR105","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1089\/10507250360731479","volume":"13","author":"M Takara","year":"2003","unstructured":"Takara, M., Kouki, T. & DeGroot, L. J. CTLA-4 AT-repeat polymorphism reduces the inhibitory function of CTLA-4 in Graves\u2019 disease. Thyroid 13, 1083\u20131089 (2003).","journal-title":"Thyroid"},{"key":"819_CR106","doi-asserted-by":"publisher","first-page":"46478","DOI":"10.1074\/jbc.M206894200","volume":"277","author":"S Anjos","year":"2002","unstructured":"Anjos, S., Nguyen, A., Ounissi-Benkalha, H., Tessier, M. C. & Polychronakos, C. A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. J. Biol. Chem. 277, 46478\u201346486 (2002).","journal-title":"J. Biol. Chem."},{"key":"819_CR107","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nri.2017.26","volume":"17","author":"K Igarashi","year":"2017","unstructured":"Igarashi, K., Kurosaki, T. & Roychoudhuri, R. BACH transcription factors in innate and adaptive immunity. Nat. Rev. Immunol. 17, 437\u2013450 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"819_CR108","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jaut.2015.10.002","volume":"67","author":"AH Sawalha","year":"2016","unstructured":"Sawalha, A. H. & Dozmorov, M. G. Epigenomic functional characterization of genetic susceptibility variants in systemic vasculitis. J. Autoimmun. 67, 76\u201381 (2016).","journal-title":"J. Autoimmun."},{"key":"819_CR109","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/BOR.0000000000000015","volume":"26","author":"A Mahr","year":"2014","unstructured":"Mahr, A. et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): evolutions in classification, etiopathogenesis, assessment and management. Curr. Opin. Rheumatol. 26, 16\u201323 (2014).","journal-title":"Curr. Opin. Rheumatol."},{"key":"819_CR110","first-page":"805","volume":"8","author":"BB Williams","year":"2015","unstructured":"Williams, B. B. et al. Glycoprotein A33 deficiency: a new mouse model of impaired intestinal epithelial barrier function and inflammatory disease. Dis. Model. Mech. 8, 805\u2013815 (2015).","journal-title":"Dis. Model. Mech."},{"key":"819_CR111","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1126\/science.1262110","volume":"348","author":"GTEx Consortium.","year":"2015","unstructured":"GTEx Consortium. Human genomics. The genotype-tissue expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 348, 648\u2013660 (2015).","journal-title":"Science"},{"key":"819_CR112","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/mi.2014.126","volume":"8","author":"CC Hui","year":"2015","unstructured":"Hui, C. C. et al. Thymic stromal lymphopoietin (TSLP) secretion from human nasal epithelium is a function of TSLP genotype. Mucosal Immunol. 8, 993\u2013999 (2015).","journal-title":"Mucosal Immunol."},{"key":"819_CR113","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/acr.20433","volume":"63","author":"R Suppiah","year":"2011","unstructured":"Suppiah, R. et al. A model to predict cardiovascular events in patients with newly diagnosed Wegener\u2019s granulomatosis and microscopic polyangiitis. Arthritis Care Res. 63, 588\u2013596 (2011).","journal-title":"Arthritis Care Res."},{"key":"819_CR114","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.2215\/CJN.01020113","volume":"8","author":"AA de Joode","year":"2013","unstructured":"de Joode, A. A., Sanders, J. S. & Stegeman, C. A. Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis. Clin. J. Am. Soc. Nephrol. 8, 1709\u20131717 (2013).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"819_CR115","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1093\/ndt\/gfu084","volume":"29","author":"LF Quintana","year":"2014","unstructured":"Quintana, L. F. et al. ANCA serotype and histopathological classification for the prediction of renal outcome in ANCA-associated glomerulonephritis. Nephrol. Dial. Transpl. 29, 1764\u20131769 (2014).","journal-title":"Nephrol. Dial. Transpl."},{"key":"819_CR116","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000615","volume":"6","author":"A Bischof","year":"2019","unstructured":"Bischof, A. et al. Peripheral neuropathy in antineutrophil cytoplasmic antibody-associated vasculitides: Insights from the DCVAS study. Neurol. Neuroimmunol. Neuroinflamm. 6, e615 (2019).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"819_CR117","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/rheumatology\/keaa215","volume":"60","author":"S Monti","year":"2021","unstructured":"Monti, S. et al. Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes. Rheumatology 60, 617\u2013628 (2021).","journal-title":"Rheumatology"},{"key":"819_CR118","doi-asserted-by":"publisher","first-page":"4654","DOI":"10.1093\/rheumatology\/keab071","volume":"60","author":"S Moiseev","year":"2021","unstructured":"Moiseev, S. et al. Association of venous thromboembolic events with skin, pulmonary and kidney involvement in ANCA-associated vasculitis: a multinational study. Rheumatology 60, 4654\u20134661 (2021).","journal-title":"Rheumatology"},{"key":"819_CR119","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1046\/j.1523-1755.2002.00089.x","volume":"61","author":"HA Hauer","year":"2002","unstructured":"Hauer, H. A. et al. Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int. 61, 80\u201389 (2002).","journal-title":"Kidney Int."},{"key":"819_CR120","doi-asserted-by":"publisher","first-page":"2004158","DOI":"10.1183\/13993003.04158-2020","volume":"57","author":"A Bettiol","year":"2021","unstructured":"Bettiol, A. et al. Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome). Eur. Respir. J. 57, 2004158 (2021).","journal-title":"Eur. Respir. J."},{"key":"819_CR121","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.3899\/jrheum.091280","volume":"37","author":"A Knight","year":"2010","unstructured":"Knight, A., Sandin, S. & Askling, J. Increased risk of autoimmune disease in families with Wegener\u2019s granulomatosis. J. Rheumatol. 37, 2553\u20132558 (2010).","journal-title":"J. Rheumatol."},{"key":"819_CR122","doi-asserted-by":"publisher","DOI":"10.1186\/s40064-015-0835-8","volume":"4","author":"J Draibe","year":"2015","unstructured":"Draibe, J. & Salama, A. D. Association of ANCA associated vasculitis and rheumatoid arthritis: a lesser recognized overlap syndrome. Springerplus 4, 50 (2015).","journal-title":"Springerplus"},{"key":"819_CR123","first-page":"5013904","volume":"2019","author":"S Itikyala","year":"2019","unstructured":"Itikyala, S., Pattanaik, D. & Raza, S. Systemic lupus erythematosus (SLE) and antineutrophil cytoplasmic antibody-associated vasculitis (AAV) overlap syndrome: case report and review of the literature. Case Rep. Rheumatol. 2019, 5013904 (2019).","journal-title":"Case Rep. Rheumatol."},{"key":"819_CR124","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10067-018-4212-1","volume":"38","author":"E Martin-Nares","year":"2019","unstructured":"Martin-Nares, E., Zuniga-Tamayo, D. & Hinojosa-Azaola, A. Prevalence of overlap of antineutrophil cytoplasmic antibody associated vasculitis with systemic autoimmune diseases: an unrecognized example of poliautoimmunity. Clin. Rheumatol. 38, 97\u2013106 (2019).","journal-title":"Clin. Rheumatol."},{"key":"819_CR125","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nri.2017.143","volume":"18","author":"CA Dendrou","year":"2018","unstructured":"Dendrou, C. A., Petersen, J., Rossjohn, J. & Fugger, L. HLA variation and disease. Nat. Rev. Immunol. 18, 325\u2013339 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"819_CR126","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1136\/annrheumdis-2015-207601","volume":"75","author":"C Rahmattulla","year":"2016","unstructured":"Rahmattulla, C. et al. Genetic variants in ANCA-associated vasculitis: a meta-analysis. Ann. Rheum. Dis. 75, 1687\u20131692 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"819_CR127","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/ng0397-289","volume":"15","author":"P Vafiadis","year":"1997","unstructured":"Vafiadis, P. et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat. Genet. 15, 289\u2013292 (1997).","journal-title":"Nat. Genet."},{"key":"819_CR128","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1056\/NEJMoa1009742","volume":"364","author":"HC Stanescu","year":"2011","unstructured":"Stanescu, H. C. et al. Risk HLA-DQA1 and PLA2R1 alleles in idiopathic membranous nephropathy. N. Engl. J. Med. 364, 616\u2013626 (2011).","journal-title":"N. Engl. J. Med."},{"key":"819_CR129","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1093\/ndt\/17.12.2077","volume":"17","author":"CA Stegeman","year":"2002","unstructured":"Stegeman, C. A. Anti-neutrophil cytoplasmic antibody (ANCA) levels directed against proteinase-3 and myeloperoxidase are helpful in predicting disease relapse in ANCA-associated small-vessel vasculitis. Nephrol. Dial. Transpl. 17, 2077\u20132080 (2002).","journal-title":"Nephrol. Dial. Transpl."},{"key":"819_CR130","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/art.33361","volume":"64","author":"M Walsh","year":"2012","unstructured":"Walsh, M. et al. Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 64, 542\u2013548 (2012).","journal-title":"Arthritis Rheum."},{"key":"819_CR131","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.3899\/jrheum.161224","volume":"44","author":"AJ Mohammad","year":"2017","unstructured":"Mohammad, A. J. et al. Pulmonary involvement in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: the influence of ANCA subtype. J. Rheumatol. 44, 1458\u20131467 (2017).","journal-title":"J. Rheumatol."},{"key":"819_CR132","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/ndt\/gfu237","volume":"30","author":"A Tanna","year":"2015","unstructured":"Tanna, A. et al. Long-term outcome of anti-neutrophil cytoplasm antibody-associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors. Nephrol. Dial. Transpl. 30, 1185\u20131192 (2015).","journal-title":"Nephrol. Dial. Transpl."},{"key":"819_CR133","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.3899\/jrheum.131038","volume":"41","author":"AJ Mohammad","year":"2014","unstructured":"Mohammad, A. J. & Segelmark, M. A population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody (ANCA)-associated nephritis versus myeloperoxidase ANCA-associated nephritis. J. Rheumatol. 41, 1366\u20131373 (2014).","journal-title":"J. Rheumatol."},{"key":"819_CR134","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1159\/000494840","volume":"48","author":"S Menez","year":"2018","unstructured":"Menez, S. et al. Predictors of renal outcomes in sclerotic class anti-neutrophil cytoplasmic antibody glomerulonephritis. Am. J. Nephrol. 48, 465\u2013471 (2018).","journal-title":"Am. J. Nephrol."},{"key":"819_CR135","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1093\/ckj\/sfaa139","volume":"14","author":"G Trivioli","year":"2021","unstructured":"Trivioli, G. et al. Slowly progressive anti-neutrophil cytoplasmic antibody-associated renal vasculitis: clinico-pathological characterization and outcome. Clin. Kidney J. 14, 332\u2013340 (2021).","journal-title":"Clin. Kidney J."},{"key":"819_CR136","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1136\/ard.2010.137778","volume":"70","author":"O Flossmann","year":"2011","unstructured":"Flossmann, O. et al. Long-term patient survival in ANCA-associated vasculitis. Ann. Rheum. Dis. 70, 488\u2013494 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"819_CR137","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1093\/rheumatology\/kez589","volume":"59","author":"ZS Wallace","year":"2020","unstructured":"Wallace, Z. S. et al. All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type. Rheumatology 59, 2308\u20132315 (2020).","journal-title":"Rheumatology"},{"key":"819_CR138","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/ki.1995.360","volume":"48","author":"M Segelmark","year":"1995","unstructured":"Segelmark, M., Elzouki, A. N., Wieslander, J. & Eriksson, S. The PiZ gene of \u03b11-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis. Kidney Int. 48, 844\u2013850 (1995).","journal-title":"Kidney Int."},{"key":"819_CR139","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.2215\/CJN.13071211","volume":"7","author":"DY Chang","year":"2012","unstructured":"Chang, D. Y., Luo, H., Zhou, X. J., Chen, M. & Zhao, M. H. Association of HLA genes with clinical outcomes of ANCA-associated vasculitis. Clin. J. Am. Soc. Nephrol. 7, 1293\u20131299 (2012).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"819_CR140","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2021081142","author":"D Chen","year":"2022","unstructured":"Chen, D. et al. Immunological interaction of HLA-DPB1 and proteinase 3 in ANCA vasculitis is associated with clinical disease activity. J. Am. Soc. Nephrol. https:\/\/doi.org\/10.1681\/ASN.2021081142 (2022).","journal-title":"J. Am. Soc. Nephrol."},{"key":"819_CR141","doi-asserted-by":"publisher","first-page":"584916","DOI":"10.1155\/2009\/584916","volume":"2009","author":"S Ohlsson","year":"2009","unstructured":"Ohlsson, S., Bakoush, O., Tencer, J., Torffvit, O. & Segelmark, M. Monocyte chemoattractant protein 1 is a prognostic marker in ANCA-associated small vessel vasculitis. Mediators Inflamm. 2009, 584916 (2009).","journal-title":"Mediators Inflamm."},{"key":"819_CR142","doi-asserted-by":"publisher","first-page":"6861257","DOI":"10.1155\/2018\/6861257","volume":"2018","author":"N J\u00f6nsson","year":"2018","unstructured":"J\u00f6nsson, N., Erlandsson, E., Gunnarsson, L., Pettersson, A. & Ohlsson, S. Monocyte chemoattractant protein-1 in antineutrophil cytoplasmic autoantibody-associated vasculitis: biomarker potential and association with polymorphisms in the MCP-1 and the CC chemokine receptor-2 gene. Mediators Inflamm. 2018, 6861257 (2018).","journal-title":"Mediators Inflamm."},{"key":"819_CR143","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/MD.0000000000000217","volume":"93","author":"C Comarmond","year":"2014","unstructured":"Comarmond, C. et al. Pulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a series of 49 patients and review of the literature. Medicine 93, 340\u2013349 (2014).","journal-title":"Medicine"},{"key":"819_CR144","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.autrev.2017.05.008","volume":"16","author":"MA Alba","year":"2017","unstructured":"Alba, M. A. et al. Interstitial lung disease in ANCA vasculitis. Autoimmun. Rev. 16, 722\u2013729 (2017).","journal-title":"Autoimmun. Rev."},{"key":"819_CR145","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/crj.13032","volume":"13","author":"W Zhao","year":"2019","unstructured":"Zhao, W. et al. Clinical features and prognosis of microscopic polyangiitis with usual interstitial pneumonia compared with idiopathic pulmonary fibrosis. Clin. Respir. J. 13, 460\u2013466 (2019).","journal-title":"Clin. Respir. J."},{"key":"819_CR146","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1136\/annrheumdis-2018-214263","volume":"78","author":"N Namba","year":"2019","unstructured":"Namba, N. et al. Association of MUC5B promoter polymorphism with interstitial lung disease in myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis. Ann. Rheum. Dis. 78, 1144\u20131146 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"819_CR147","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1056\/NEJMoa1013660","volume":"364","author":"MA Seibold","year":"2011","unstructured":"Seibold, M. A. et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N. Engl. J. Med. 364, 1503\u20131512 (2011).","journal-title":"N. Engl. J. Med."},{"key":"819_CR148","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1801562","volume":"379","author":"PA Juge","year":"2018","unstructured":"Juge, P. A. et al. MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease. N. Engl. J. Med. 379, 2209\u20132219 (2018).","journal-title":"N. Engl. J. Med."},{"key":"819_CR149","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1002\/art.24957","volume":"60","author":"MD Morgan","year":"2009","unstructured":"Morgan, M. D. et al. Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: a matched-pair cohort study. Arthritis Rheum. 60, 3493\u20133500 (2009).","journal-title":"Arthritis Rheum."},{"key":"819_CR150","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3899\/jrheum.170896","volume":"46","author":"A Kang","year":"2019","unstructured":"Kang, A. et al. High incidence of arterial and venous thrombosis in antineutrophil cytoplasmic antibody-associated vasculitis. J. Rheumatol. 46, 285\u2013293 (2019).","journal-title":"J. Rheumatol."},{"key":"819_CR151","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1073\/pnas.1616301114","volume":"114","author":"R Malik","year":"2017","unstructured":"Malik, R. et al. Common coding variant in SERPINA1 increases the risk for large artery stroke. Proc. Natl Acad. Sci. USA 114, 3613\u20133618 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"819_CR152","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1161\/STROKEAHA.111.000217","volume":"44","author":"HS Markus","year":"2013","unstructured":"Markus, H. S. et al. Evidence HDAC9 genetic variant associated with ischemic stroke increases risk via promoting carotid atherosclerosis. Stroke 44, 1220\u20131225 (2013).","journal-title":"Stroke"},{"key":"819_CR153","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1038\/s41588-019-0514-8","volume":"51","author":"R Malhotra","year":"2019","unstructured":"Malhotra, R. et al. HDAC9 is implicated in atherosclerotic aortic calcification and affects vascular smooth muscle cell phenotype. Nat. Genet. 51, 1580\u20131587 (2019).","journal-title":"Nat. Genet."},{"key":"819_CR154","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1136\/annrheumdis-2014-206404","volume":"74","author":"RB Jones","year":"2015","unstructured":"Jones, R. B. et al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial. Ann. Rheum. Dis. 74, 1178\u20131182 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"819_CR155","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa0909905","volume":"363","author":"JH Stone","year":"2010","unstructured":"Stone, J. H. et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N. Engl. J. Med. 363, 221\u2013232 (2010).","journal-title":"N. Engl. J. Med."},{"key":"819_CR156","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1136\/annrheumdis-2019-216863","volume":"79","author":"RM Smith","year":"2020","unstructured":"Smith, R. M. et al. Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis. Ann. Rheum. Dis. 79, 1243\u20131249 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"819_CR157","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1056\/NEJMoa1803537","volume":"382","author":"M Walsh","year":"2020","unstructured":"Walsh, M. et al. Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis. N. Engl. J. Med. 382, 622\u2013631 (2020).","journal-title":"N. Engl. J. Med."},{"key":"819_CR158","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","volume":"75","author":"M Yates","year":"2016","unstructured":"Yates, M. et al. EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann. Rheum. Dis. 75, 1583\u20131594 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"819_CR159","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1093\/rheumatology\/key319","volume":"58","author":"AC Hessels","year":"2019","unstructured":"Hessels, A. C. et al. Clinical outcome in anti-neutrophil cytoplasmic antibody-associated vasculitis and gene variants of 11beta-hydroxysteroid dehydrogenase type 1 and the glucocorticoid receptor. Rheumatology 58, 447\u2013454 (2019).","journal-title":"Rheumatology"},{"key":"819_CR160","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/nrendo.2013.183","volume":"9","author":"RA Quax","year":"2013","unstructured":"Quax, R. A. et al. Glucocorticoid sensitivity in health and disease. Nat. Rev. Endocrinol. 9, 670\u2013686 (2013).","journal-title":"Nat. Rev. Endocrinol."},{"key":"819_CR161","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1046\/j.1365-2265.2003.01888.x","volume":"59","author":"EF van Rossum","year":"2003","unstructured":"van Rossum, E. F. et al. Identification of the BclI polymorphism in the glucocorticoid receptor gene: association with sensitivity to glucocorticoids in vivo and body mass index. Clin. Endocrinol. 59, 585\u2013592 (2003).","journal-title":"Clin. Endocrinol."},{"key":"819_CR162","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1016\/j.jaci.2016.08.051","volume":"139","author":"F Alberici","year":"2017","unstructured":"Alberici, F. et al. Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody-associated vasculitis. J. Allergy Clin. Immunol. 139, 1684\u20131687.e10 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"819_CR163","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1093\/rheumatology\/ken246","volume":"47","author":"JC Nossent","year":"2008","unstructured":"Nossent, J. C., Lester, S., Zahra, D., Mackay, C. R. & Rischmueller, M. Polymorphism in the 5\u2032 regulatory region of the B-lymphocyte activating factor gene is associated with the Ro\/La autoantibody response and serum BAFF levels in primary Sjogren\u2019s syndrome. Rheumatology 47, 1311\u20131316 (2008).","journal-title":"Rheumatology"},{"key":"819_CR164","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/art.37707","volume":"65","author":"M Fabris","year":"2013","unstructured":"Fabris, M. et al. The TTTT B lymphocyte stimulator promoter haplotype is associated with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to tumor necrosis factor blockers. Arthritis Rheum. 65, 88\u201397 (2013).","journal-title":"Arthritis Rheum."},{"key":"819_CR165","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/ncprheum0424","volume":"3","author":"RP Taylor","year":"2007","unstructured":"Taylor, R. P. & Lindorfer, M. A. Drug insight: the mechanism of action of rituximab in autoimmune disease-the immune complex decoy hypothesis. Nat. Clin. Pract. Rheumatol. 3, 86\u201395 (2007).","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"819_CR166","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1182\/blood-2011-01-330357","volume":"118","author":"SH Lim","year":"2011","unstructured":"Lim, S. H. et al. Fc gamma receptor IIb on target B cells promotes rituximab internalization and reduces clinical efficacy. Blood 118, 2530\u20132540 (2011).","journal-title":"Blood"},{"key":"819_CR167","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1136\/annrheumdis-2011-200337","volume":"71","author":"A Ruyssen-Witrand","year":"2012","unstructured":"Ruyssen-Witrand, A. et al. Fc\u03b3 receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab. Ann. Rheum. Dis. 71, 875\u2013877 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"819_CR168","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/art.39822","volume":"69","author":"R Cartin-Ceba","year":"2017","unstructured":"Cartin-Ceba, R. et al. The pharmacogenomic association of Fc\u03b3 receptors and cytochrome P450 enzymes with response to rituximab or cyclophosphamide treatment in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol. 69, 169\u2013175 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"819_CR169","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2217\/pgs.15.176","volume":"17","author":"JH Schirmer","year":"2016","unstructured":"Schirmer, J. H. et al. Cyclophosphamide treatment-induced leukopenia rates in ANCA-associated vasculitis are influenced by variant CYP450 2C9 genotypes. Pharmacogenomics 17, 367\u2013374 (2016).","journal-title":"Pharmacogenomics"},{"key":"819_CR170","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1093\/ndt\/gfq852","volume":"26","author":"R Cartin-Ceba","year":"2011","unstructured":"Cartin-Ceba, R., Keogh, K. A., Specks, U., Sethi, S. & Fervenza, F. C. Rituximab for the treatment of Churg-Strauss syndrome with renal involvement. Nephrol. Dial. Transpl. 26, 2865\u20132871 (2011).","journal-title":"Nephrol. Dial. Transpl."},{"key":"819_CR171","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1136\/annrheumdis-2014-206095","volume":"75","author":"AJ Mohammad","year":"2016","unstructured":"Mohammad, A. J. et al. Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Ann. Rheum. Dis. 75, 396\u2013401 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"819_CR172","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2019-000905","volume":"5","author":"V Teixeira","year":"2019","unstructured":"Teixeira, V., Mohammad, A. J., Jones, R. B., Smith, R. & Jayne, D. Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis. RMD Open 5, e000905 (2019).","journal-title":"RMD Open"},{"key":"819_CR173","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1056\/NEJMoa1702079","volume":"376","author":"ME Wechsler","year":"2017","unstructured":"Wechsler, M. E. et al. Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis. N. Engl. J. Med. 376, 1921\u20131932 (2017).","journal-title":"N. Engl. J. Med."},{"key":"819_CR174","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/art.41943","volume":"74","author":"A Bettiol","year":"2022","unstructured":"Bettiol, A. et al. Mepolizumab for eosinophilic granulomatosis with polyangiitis: a European multicenter observational study. Arthritis Rheumatol. 74, 295\u2013306 (2022).","journal-title":"Arthritis Rheumatol."},{"key":"819_CR175","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.1093\/rheumatology\/keaa134","volume":"59","author":"F Alberici","year":"2020","unstructured":"Alberici, F. et al. FCGR3B polymorphism predicts relapse risk in eosinophilic granulomatosis with polyangiitis. Rheumatology 59, 3563\u20133566 (2020).","journal-title":"Rheumatology"}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41584-022-00819-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-022-00819-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-022-00819-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T07:31:28Z","timestamp":1676791888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-022-00819-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,15]]},"references-count":175,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["819"],"URL":"https:\/\/doi.org\/10.1038\/s41584-022-00819-y","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,15]]},"assertion":[{"value":"21 July 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}